SEC Form 4 · accession 0001225208-18-001052
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Weir Mirian M Graddick
Officer — Exe V-P, HR
Period of report
Jan 12, 2018
Accepted (ET)
Jan 16, 2018 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 12, 2018 | S | 5,000 | $58.00 | D | 101,484 | D | |
| Common Stock | Jan 16, 2018 | M | 52,000 | $44.30 | A | 153,484 | D | |
| Common Stock | Jan 16, 2018 | S | 8,000 | $61.63 | D | 145,484 | D | |
| Common StockF3 | Jan 16, 2018 | S | 52,000 | $61.63 | D | 93,484 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $44.30 | Jan 16, 2018 | M | 52,000 | D | Feb 28, 2009 | Feb 28, 2018 | Common Stock | 52,000 | 0 | D |
Explanation of responses
- F1The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
- F2The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F3Holdings include shares acquired in dividend reinvestment transactions.
- F4The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.
Remarks
poagraddickweir.txt